DK0561827T3 - Tetrapeptider stammende fra dalbaheptidantibiotika - Google Patents

Tetrapeptider stammende fra dalbaheptidantibiotika

Info

Publication number
DK0561827T3
DK0561827T3 DK91920590.6T DK91920590T DK0561827T3 DK 0561827 T3 DK0561827 T3 DK 0561827T3 DK 91920590 T DK91920590 T DK 91920590T DK 0561827 T3 DK0561827 T3 DK 0561827T3
Authority
DK
Denmark
Prior art keywords
group
tetrapeptides
carboxyacid
dalbaheptide
aglucodalbaheptides
Prior art date
Application number
DK91920590.6T
Other languages
Danish (da)
English (en)
Inventor
Adriano Malabarba
Romeo Ciabatti
Original Assignee
Lepetit Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lepetit Spa filed Critical Lepetit Spa
Application granted granted Critical
Publication of DK0561827T3 publication Critical patent/DK0561827T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K9/00Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K9/00Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/006Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure
    • C07K9/008Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure directly attached to a hetero atom of the saccharide radical, e.g. actaplanin, avoparcin, ristomycin, vancomycin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10Tetrapeptides
    • C07K5/1002Tetrapeptides with the first amino acid being neutral
    • C07K5/1016Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK91920590.6T 1990-12-10 1991-11-28 Tetrapeptider stammende fra dalbaheptidantibiotika DK0561827T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP90123672 1990-12-10

Publications (1)

Publication Number Publication Date
DK0561827T3 true DK0561827T3 (da) 1995-07-03

Family

ID=8204819

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91920590.6T DK0561827T3 (da) 1990-12-10 1991-11-28 Tetrapeptider stammende fra dalbaheptidantibiotika

Country Status (10)

Country Link
EP (1) EP0561827B1 (de)
JP (1) JP3276632B2 (de)
KR (1) KR100202250B1 (de)
AT (1) ATE121101T1 (de)
CA (1) CA2098098C (de)
DE (1) DE69108930T2 (de)
DK (1) DK0561827T3 (de)
ES (1) ES2071346T3 (de)
IE (1) IE914265A1 (de)
WO (1) WO1992010517A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE159533T1 (de) * 1993-05-19 1997-11-15 Biosearch Italia Spa Syntetische aglukodalbaheptid-antibiotika

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2110401T3 (es) * 1989-07-18 1998-02-16 Biosearch Italia Spa Antibioticos pentapeptidicos derivados de dalbaheptidos.

Also Published As

Publication number Publication date
ES2071346T3 (es) 1995-06-16
JPH06503307A (ja) 1994-04-14
CA2098098A1 (en) 1992-06-10
KR100202250B1 (ko) 1999-06-15
DE69108930T2 (de) 1995-08-24
EP0561827A1 (de) 1993-09-29
ATE121101T1 (de) 1995-04-15
JP3276632B2 (ja) 2002-04-22
EP0561827B1 (de) 1995-04-12
IE914265A1 (en) 1992-06-17
CA2098098C (en) 2003-04-08
KR930703358A (ko) 1993-11-29
WO1992010517A1 (en) 1992-06-25
DE69108930D1 (de) 1995-05-18

Similar Documents

Publication Publication Date Title
ZA892474B (en) Process for preparing derivatives of baccatine iii and of 10-deacetyl baccatine iii
FR2733244B1 (fr) Systeme de stabilisants a base de derives de polyalkylpiperidine
ES2139079T3 (es) Compuestos inmunosupresores y antialergicos, tales como n-(3-oxohexanoil)-homoserina-lactona.
SE8502017L (sv) 1,4-dihydro-4-oxonaftyridinderivat och salter derav, forfarande for framstellning av dessa jemte antibakteriella medel innefattande dessa
ES507716A0 (es) Procedimiento para preparar derivados de 2-oxoazetidina .
FI893842A0 (fi) Menetelmä uuden antibiootin, mersasidiinin, valmistamiseksi
DK0561827T3 (da) Tetrapeptider stammende fra dalbaheptidantibiotika
DE69406441D1 (de) Syntetische aglukodalbaheptid-antibiotika
ATE132876T1 (de) Hexapeptidderivate von teicoplanin und verfahren zu deren herstellung
ECSP972170A (es) Compuestos para el tratamiento de infecciones bacterianas
ATE113047T1 (de) 2-fluorneplanocin a und seine herstellung.
DK0570443T3 (da) Aminoalkoholer, der er egnede som midler til optisk opløsning